These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 15084363)
1. Treating electrical instability in sudden cardiac death survivors -- are we looking at the right side of the coin? Weber H; Allikmets K; Kornfeld G Eur Heart J; 2004 Apr; 25(8):623-5. PubMed ID: 15084363 [No Abstract] [Full Text] [Related]
2. Implantable cardioverter defibrillator therapy for non-ischaemic cardiomyopathy. What is the role of programmed electrical stimulation? Plummer C Europace; 2009 Mar; 11(3):273-5. PubMed ID: 19164361 [No Abstract] [Full Text] [Related]
3. Efficacy of implantable cardioverter-defibrillators: from trials to the real world. De Sousa J Rev Port Cardiol; 2005 Apr; 24(4):501-4. PubMed ID: 15977774 [No Abstract] [Full Text] [Related]
4. The evolution and revolution of the implantable cardioverter defibrillator. Indik JH Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):461-4. PubMed ID: 15225105 [No Abstract] [Full Text] [Related]
5. Clinical trials update: sudden cardiac death prevention by implantable device therapy. Finch NJ; Leman RB Crit Care Nurs Clin North Am; 2005 Mar; 17(1):33-8, x. PubMed ID: 15749399 [TBL] [Abstract][Full Text] [Related]
6. [What information is given by controlled clinical trials (pharmacological and nonpharmacological) for anti-arrhythmia therapy in the prevention of sudden death?]. Naccarella F; Croci F G Ital Cardiol; 1996 Nov; 26(11):1345-64. PubMed ID: 9036037 [No Abstract] [Full Text] [Related]
7. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of sudden cardiac death in myocardial infarction survivors: insights from the randomized trials of implantable cardioverter-defibrillators. Bunch TJ; Hohnloser SH; Gersh BJ Circulation; 2007 May; 115(18):2451-7. PubMed ID: 17485594 [No Abstract] [Full Text] [Related]
9. Sudden cardiac death and channelopathies: a review of implantable defibrillator therapy. Choi GR; Porter CB; Ackerman MJ Pediatr Clin North Am; 2004 Oct; 51(5):1289-303. PubMed ID: 15331285 [TBL] [Abstract][Full Text] [Related]
10. The high cost of implantable defibrillators. Hlatky MA; Mark DB Eur Heart J; 2007 Feb; 28(4):388-91. PubMed ID: 17032689 [TBL] [Abstract][Full Text] [Related]
13. Randomized clinical trials: how long should they last? Wellens HJ Circulation; 2004 Jul; 110(2):107-8. PubMed ID: 15249514 [No Abstract] [Full Text] [Related]
14. [Sudden cardiac death after myocardial infarct. ICD and omega 3 fatty acids without preventive effect]. Einecke D MMW Fortschr Med; 2009 Apr; 151(16):14. PubMed ID: 19658288 [No Abstract] [Full Text] [Related]
15. ICD therapy: what have we learned from the clinical trials? Arya A; Haghjoo M; Sadr-Ameli MA Heart Lung Circ; 2006 Feb; 15(1):3-11. PubMed ID: 16473784 [TBL] [Abstract][Full Text] [Related]
18. Sudden death prevention with implantable devices. Passman R; Kadish A Circulation; 2007 Jul; 116(5):561-71. PubMed ID: 17664385 [No Abstract] [Full Text] [Related]
19. Short QT syndrome and arrhythmogenic cardiac diseases in the young: the challenge of implantable cardioverter-defibrillator therapy for children. Boriani G; Biffi M; Valzania C; Bronzetti G; Martignani C Eur Heart J; 2006 Oct; 27(20):2382-4. PubMed ID: 16952927 [No Abstract] [Full Text] [Related]